Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07365514 · ClinicalTrials.gov registry record · Phase 1
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
A Phase 1 study, sponsored by University of Connecticut.
- Not yet
- Registry status
- Phase 1
- Development phase
- 159
- Enrollment target
NCT07365514 is a Phase 1 study that has not yet begun recruiting, run by University of Connecticut. The registered enrollment target is 159 participants.
The verdict
NCT07365514, a Phase 1 study, has not yet begun recruiting, sponsored by University of Connecticut.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 159 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
Interventions
- DRUG Placebo
- DRUG Blackcurrant (BC) extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2029-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07365514
The ClinicalTrials.gov registry entry for NCT07365514 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07365514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07365514 about?
NCT07365514 is a clinical study titled "Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females". The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.
What is the current status of trial NCT07365514?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 159 participants. The study started on 2026-02-01. Estimated completion is 2029-09.
What interventions are being tested in trial NCT07365514?
The interventions under investigation include: Placebo (DRUG), Blackcurrant (BC) extract (DRUG).
Who is sponsoring clinical trial NCT07365514?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.